Aduhelm Biogen - Search Videos

First new drug for Alzheimer's in 20 years approved by FDA

First new drug for Alzheimer's in 20 years approved by FDA

The Food and Drug Administration has granted approval to a drug called Aduhelm, developed by Biogen, for patients with Alzheimer's disease. The decision comes despite warnings from independent advisers that there isn't strong enough evidence to prove the treatment is effective in slowing the disease. Read more here .

Related Products

Biogen Aduhelm FDA Label Carton

#What Is Aducanumab

23 reactions · 13 shares | Aducanumab fue la primera terapia en demostrar que la eliminación de la beta-amiloide, una de las características distintivas de la enfermedad de Alzheimer, del cerebro reduce el deterioro cognitivo y funcional en las personas que viven con Alzheimer temprano. 易 . . . . . . . #alzheimers #tratamento #medicina #ciencia #medicinaysalud #neuroprevencion #neurology #doctorbello | Doctor Bello | Facebook

23 reactions · 13 shares | Aducanumab fue la primera terapia en demostrar que la eliminación de la beta-amiloide, una de las características distintivas de la enfermedad de Alzheimer, del cerebro reduce el deterioro cognitivo y funcional en las personas que viven con Alzheimer temprano. 易 . . . . . . . #alzheimers #tratamento #medicina #ciencia #medicinaysalud #neuroprevencion #neurology #doctorbello | Doctor Bello | Facebook

Facebook2 weeks ago

Leading Canadian researchers say Alzheimer’s drug aducanumab should not be approved in Canada, at least not yet — despite being approved by the U.S. FDA. Reporting by Christine Birak | CBC News: The National

Leading Canadian researchers say Alzheimer’s drug aducanumab should not be approved in Canada, at least not yet — despite being approved by the U.S. FDA. Reporting by Christine Birak | CBC News: The National

FacebookAug 13, 2021

Top videos

Biogen Investigates Death of Aduhelm Patient

Biogen Investigates Death of Aduhelm Patient

FDA and Biogen's push to accelerate approval of Alzheimer's drug

FDA and Biogen's push to accelerate approval of Alzheimer's drug

Biogen shares drop as big clinics announce they won't administer controversial Alzheimer's drug

Biogen shares drop as big clinics announce they won't administer controversial Alzheimer's drug

Aducanumab Alzheimers Treatment

Aduhelm is FDA Approved for Alzheimer's, But Does it Work?

Aduhelm is FDA Approved for Alzheimer's, But Does it Work?

YouTubeHealthcare Triage

17.4K viewsJul 29, 2021

Lecanemab in Alzheimer’s Disease | NEJM

Lecanemab in Alzheimer’s Disease | NEJM

YouTubeNEJM Group

24.5K viewsJan 5, 2023

Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, Aducanumab

Controversy Around FDA’s Approval of Biogen Alzheimer’s Drug, Aducanumab

YouTubeNutritionFacts.org

21.1K viewsOct 23, 2023

Biogen Investigates Death of Aduhelm Patient

Biogen Investigates Death of Aduhelm Patient

FDA and Biogen's push to accelerate approval of Alzheimer's drug

FDA and Biogen's push to accelerate approval of Alzheimer'…

Biogen shares drop as big clinics announce they won't administer controversial Alzheimer's drug

Biogen shares drop as big clinics announce they won't administer c…

Les interactions entre Biogen et la FDA avant l'approbation d'Aduhelm sont considérées comme "atypiques", selon un rapport de la Chambre des représentants des États-Unis.

Les interactions entre Biogen et la FDA avant l'approbation d'Aduhel…

FDA Faulted for Working Improperly With Biogen Before Clearing Alzheimer’s Drug

FDA Faulted for Working Improperly With Biogen Before Clearing Alzh…

Biogen interrompt le développement de l'Aduhelm, son ancien médicament contre la maladie d'Alzheimer

Biogen interrompt le développement de l'Aduhelm, son ancien médica…

Change at the top for Biogen after Alzheimer's drug flops

Change at the top for Biogen after Alzheimer's drug flops

Biogen discontinues Alzheimer’s medication Aduhelm - Local News 8

66 reactions · 4 comments | We’re committed to helping Multiple Scl…

23K views2 weeks ago

Biogen Cuts Price for Alzheimer’s Drug Aduhelm by Half

Could Advocacy Groups' Campaign for Aduhelm Benefit Biogen? | Th…

Biogen plans to shut down its controversial Alzheimer’s drug Ad…

torontosunAssociated Press,Tom Murphy

1.2K views · 42 reactions | The Olympics and Paralympics bring...

273 views2 weeks ago

Samsung in Talks to Buy Alzheimer’s Drug Maker for $42 Bi…

360 viewsDec 30, 2021

1.7K reactions · 12 shares | We believe accessible travel should b…

209.1K views2 weeks ago

While Alyssa battles physical weakness daily, it’s her journey o…

51.1K views2 weeks ago

Aducanumab (Aduhelm) For Alzheimer’s Disease » Departmen…

Reveal your natural glow and support your active lifestyle with …

44.9K views5 months ago

19 reactions | As people age, they may notice changes in their abilit…

2K views1 week ago

30 reactions · 3 comments | To mark the 5th anniversary of the Paris...

2K views3 weeks ago

35K views · 229 reactions | The U.S. burden of Alzheimer’s disease...

35.2K views2 weeks ago

19 reactions | As the number of adults living with Alzheimer’s and …

2K views1 week ago

Medicare proposes only covering Alzheimer's drug Aduhelm for clin…

CBS NewsAimee Picchi

73 reactions · 13 shares | For more than 100 years scientists have...

26.4K views2 weeks ago

The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug

Biogen Names Christopher Viehbacher New CEO

WSJJoseph Walker,Colin Kellaher

3.1K views · 37 reactions | The journey toward accessible air trav…

1.2K views2 weeks ago

Biogen cuts the price tag on its Alzheimer's drug in half

288.9K viewsDec 20, 2021

YahooYahoo News Video

FDA narrows label for Biogen’s Alzheimer’s drug

31.1K viewsJul 8, 2021

YahooReuters Videos

See more videos